BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND SPEN, Q96T58, 23013, ENSG00000065526, SHARP, RP1-134O19_1, MINT, KIAA0929 AND Staging
1119 results:

  • 1. [The efficacy and safety of laparoscopic radical gastrectomy after neoadjuvant chemotherapy combined with immunotherapy and targeted therapy].
    Shao XX; Li WK; Hu HT; Lu YM; Jiang YJ; Tian YT
    Zhonghua Yi Xue Za Zhi; 2024 Apr; 104(16):1397-1402. PubMed ID: 38644290
    [No Abstract]    [Full Text] [Related]  

  • 2. Nomogram to predict overall survival of patients receiving radical gastrectomy and incomplete peri-operative adjuvant chemotherapy for stage II/III gastric cancer: a retrospective bi-center cohort study.
    Liu D; Quan H; Ma M; Zhou H; Yang X; Wu Z; Luo J; Xiao H; Xiao Y
    BMC Cancer; 2024 Mar; 24(1):344. PubMed ID: 38500085
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Perioperative factors associated with survival following surgery for pancreatic cancer - a nationwide analysis of 473 cases from Denmark.
    Spore LM; Dencker EE; Kvanner EA; Hansen CP; Burgdorf SK; Krohn PS; Kollbeck SLG; Storkholm JH; Sillesen M
    BMC Surg; 2024 Mar; 24(1):76. PubMed ID: 38431571
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Prognostic value of CT-based radiomics in grade 1-2 pancreatic neuroendocrine tumors.
    Heo S; Park HJ; Kim HJ; Kim JH; Park SY; Kim KW; Kim SY; Choi SH; Byun JH; Kim SC; Hwang HS; Hong SM
    Cancer Imaging; 2024 Feb; 24(1):28. PubMed ID: 38395973
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Predicting the unpredictable: a robust nomogram for predicting recurrence in patients with ampullary carcinoma.
    Chen R; Zhu L; Zhang Y; Cui D; Chen R; Guo H; Peng L; Xiao C
    BMC Cancer; 2024 Feb; 24(1):212. PubMed ID: 38360582
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Volumetric Parameters Derived from CXCR4-Directed PET/CT Predict Outcome in Patients with Gastrointestinal Neuroendocrine Carcinomas.
    Michalski K; Schlötelburg W; Hartrampf P; Heinrich M; Serfling S; Buck AK; Werner RA; Kosmala A; Weich A
    Mol Imaging Biol; 2024 Apr; 26(2):344-350. PubMed ID: 38332341
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A novel investigation into the negative impact of opioid use on the efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer patients.
    Guo H; Li Y; Lin J; Li D; Yang J; Wang J; Mao J; Wang Y; Yan X
    Int Immunopharmacol; 2024 Mar; 129():111611. PubMed ID: 38325047
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Improved Clinical staging System for Localized pancreatic cancer Using the ABC Factors: A TAPS Consortium Study.
    Dekker EN; van Dam JL; Janssen QP; Besselink MG; DeSilva A; Doppenberg D; van Eijck CHJ; Nasar N; O'Reilly EM; Paniccia A; Prakash LR; Tzeng CD; Verkolf EMM; Wei AC; Zureikat AH; Katz MHG; Groot Koerkamp B;
    J Clin Oncol; 2024 Apr; 42(12):1357-1367. PubMed ID: 38315954
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Optimizing hepatocellular carcinoma disease staging systems by incorporating tumor micronecrosis: A multi-institutional retrospective study.
    Wang Y; Sun X; Chen C; Ge H; Sun J; Li E; Cai Z; Fu Q; Sun X; Wu J; Ye M; Cao W; Chen Q; Wei X; Han X; Sun K; Yan Q; Huang W; Wu L; Zeng Y; Zhang Q; Liang T
    Cancer Lett; 2024 Mar; 585():216654. PubMed ID: 38272344
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Adjuvant immunotherapy improves recurrence-free and overall survival following surgical resection for intermediate/advanced hepatocellular carcinoma
    Xu X; Wang MD; Xu JH; Fan ZQ; Diao YK; Chen Z; Jia HD; Liu FB; Zeng YY; Wang XM; Wu H; Qiu W; Li C; Pawlik TM; Lau WY; Shen F; Lv GY; Yang T
    Front Immunol; 2023; 14():1322233. PubMed ID: 38268916
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Survival of patients with pancreatic ductal adenocarcinoma].
    Targarona J; Rivero L; Coayla G; Roman G; Rivas D; Legua S; Carrasco R
    Rev Gastroenterol Peru; 2023; 43(4):300-308. PubMed ID: 38228295
    [TBL] [Abstract] [Full Text] [Related]  

  • 12.
    Li X; Lu N; Lin L; Chen Y; Yang S; Wang H; Liu X; Wu C; Xue X; Su X; Bai X; Liang T
    J Nucl Med; 2024 Feb; 65(2):206-212. PubMed ID: 38176719
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Serum CEA as a Prognostic Marker for Overall Survival in Patients with Localized pancreatic Adenocarcinoma and Non-Elevated CA19-9 Levels Treated with FOLFIRINOX as Initial Treatment: A TAPS Consortium Study.
    Doppenberg D; Stoop TF; van Dieren S; Katz MHG; Janssen QP; Nasar N; Prakash LR; Theijse RT; Tzeng CD; Wei AC; Zureikat AH; Groot Koerkamp B; Besselink MG;
    Ann Surg Oncol; 2024 Mar; 31(3):1919-1932. PubMed ID: 38170408
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Impact of Recombinant Granulocyte Colony-Stimulating Factor During Neoadjuvant Therapy on Outcomes of Resected pancreatic cancer.
    Murthy P; Zenati MS; AlMasri SS; DeSilva A; Singhi AD; Paniccia A; Lee KK; Simmons RL; Bahary N; Lotze MT; Zureikat AH
    J Natl Compr Canc Netw; 2023 Dec; 22(1D):e237070. PubMed ID: 38150819
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Impact of sex on treatment decisions and outcome in patients with neuroendocrine neoplasms.
    Beck J; Siebenhüner A; Wild D; Christ E; Refardt J
    Endocr Relat Cancer; 2024 Mar; 31(3):. PubMed ID: 38117915
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Inadequacy of the eighth edition of the American Joint Committee on cancer pancreatic cancer staging system for invasive carcinoma associated with premalignant lesions in the pancreas: an analysis using the National cancer Database.
    Jung HS; Lee M; Han Y; Thomas AS; Yun WG; Cho YJ; Kluger MD; Jang JY; Kwon W
    HPB (Oxford); 2024 Mar; 26(3):400-409. PubMed ID: 38114399
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Combined utility of Ki-67 index and tumor grade to stratify patients with pancreatic ductal adenocarcinoma who underwent upfront surgery.
    Li B; Yin X; Ding X; Zhang G; Jiang H; Chen C; Guo S; Jin G
    BMC Surg; 2023 Dec; 23(1):370. PubMed ID: 38066512
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Prognostic Value of Serum α-Fetoprotein Level as an Important Characteristic of Tumor Biology for Patients Undergoing Liver Resection of Early-Stage Hepatocellular Carcinoma (BCLC Stage 0/A): A Large Multicenter Analysis.
    Yao LQ; Fan ZQ; Wang MD; Diao YK; Chen TH; Zeng YY; Chen Z; Wang XM; Zhou YH; Li J; Fan XP; Liang YJ; Li C; Shen F; Lv GY; Yang T
    Ann Surg Oncol; 2024 Feb; 31(2):1219-1231. PubMed ID: 37925654
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Efficacy of staging Laparoscopy in Patients With pancreatic cancer: A Single Center Prospective Cohort Study.
    Shindo Y; Tokumitsu Y; Matsui H; Nakajima M; Kimura Y; Iida M; Suzuki N; Takeda S; Ioka T; Nagano H
    In Vivo; 2023; 37(6):2704-2709. PubMed ID: 37905607
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Unique Biology of pancreatic Ductal Adenocarcinoma Accompanied by Rapidly Impaired Diabetes: A Favorable Long-Term Survival Following Curative Resection.
    Kiritani S; Ono Y; Takamatsu M; Yoshio S; Miyashita M; Oba A; Sato T; Ito H; Inoue Y; Saiura A; Takahashi Y
    Ann Surg Oncol; 2024 Jan; 31(1):514-524. PubMed ID: 37803089
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 56.